ArticleCancer chemotherapy and pharmacology2022

Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies.

Elmira Karami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.